Holen Sie sich die Stockscreener-App
0.3904
3.10%
-0.0125
Handel nachbörslich:
.40
0.0096
+2.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.4029
Offen:
$0.4031
24-Stunden-Volumen:
713.86K
Relative Volume:
0.34
Marktkapitalisierung:
$16.22M
Einnahmen:
$62.71M
Nettoeinkommen (Verlust:
$-10.48M
KGV:
-0.6197
EPS:
-0.63
Netto-Cashflow:
$-13.77M
1W Leistung:
-6.15%
1M Leistung:
+16.19%
6M Leistung:
-23.62%
1J Leistung:
-87.45%
1-Tages-Spanne:
$0.375
$0.41
1-Wochen-Bereich:
$0.35
$0.43
52-Wochen-Spanne:
$0.2179
$3.3654
Prophase Labs Inc Stock (PRPH) Company Profile
Firmenname
Prophase Labs Inc
Sektor
Branche
Telefon
(215) 345-0919
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Vergleichen Sie PRPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.3904 | 17.28M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-13 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-01-20 | Eingeleitet | Dawson James | Buy |
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
What drives ProPhase Labs Inc. stock priceUnprecedented profits - jammulinksnews.com
ProPhase Labs Board of Directors Authorizes Management to - GlobeNewswire
Why ProPhase Labs Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Is ProPhase Labs Inc. a good long term investmentDynamic growth stocks - jammulinksnews.com
ProPhase Labs Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com
Prophase Labs Explores Reverse Merger with Digital Asset Firm - TipRanks
ProPhase Labs explores reverse merger with digital asset company - Investing.com
ProPhase Labs explores strategic reverse merger and approves crypto treasury initiative. - AInvest
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - The Globe and Mail
ProPhase Labs Makes Bold Crypto Move: Plans Reverse Merger While Protecting $50M Healthcare Portfolio - Stock Titan
What makes ProPhase Labs Inc. stock price move sharplyHigh Potential Safe Trades - beatles.ru
What analysts say about ProPhase Labs Inc. stockExceptional trading performance - Autocar Professional
Prophase Labs shares rise 1.88% after-hours following an investor presentation. - AInvest
Prophase Labs shares fall 10.58% intraday after investor presentation. - AInvest
How ProPhase Labs Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
ProPhase Labs Regains Nasdaq Compliance with New Appointment - The Globe and Mail
PCSA ends Ocuphire licensing deal, starts portfolio review – Form 8-K - Stock Titan
Prophase Labs Secures $1M in New Loan Agreements - TipRanks
ProPhase Labs, Inc. Receives Additional 180 Day Extension from N - GuruFocus
ProPhase Labs, Inc. Receives Additional 180 Day Extension - GlobeNewswire
ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule - MarketScreener
Prophase Labs Appoints Carolina Abenante as Director - TipRanks
ProPhase Labs appoints Carolina Abenante as independent director By Investing.com - Investing.com UK
ProPhase Labs, Inc. announced that it expects to receive $0.5 million in funding - MarketScreener
ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus
ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus
Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener
ProPhase Labs Inc. Validates BE-Smart™ Diagnostic Test for Esophageal Disease with Over 95% Success Rate - Nasdaq
ProPhase Labs Announces Successful Study Demonstrating - GlobeNewswire
Breakthrough: ProPhase's New Cancer Test Shows 95% Success Rate, Targets $10B Market - Stock Titan
ProPhase Labs Inc (PRPH)’s Market Momentum: Closing Strong at 0.33, Down -2.56 - DWinneX
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN
52,394 Shares in ProPhase Labs, Inc. (NASDAQ:PRPH) Acquired by Squarepoint Ops LLC - Defense World
ProPhase Labs Announces Formation of Clinical Science Advisory B - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Tes - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Test Commercialization | PRPH Stock News - GuruFocus
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform | PRPH Stock News - GuruFocus
ProPhase Labs Inc. Establishes Clinical Science Advisory Board to Advance BE-SmartTM Test for Esophageal Disease Detection - Nasdaq
ProPhase Labs forms advisory board for esophageal test - Investing.com
ProPhase Labs Announces Formation of Clinical Science - GlobeNewswire
ProPhase Labs Targets $14 Billion Market with Revolutionary Esophageal Cancer Detection Platform - Stock Titan
Finanzdaten der Prophase Labs Inc-Aktie (PRPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):